GE HealthCare Techs Q4 Adjusted EPS $1.18 Beats $1.07 Estimate, Sales $5.21B Beat $5.09B Estimate
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Techs (NASDAQ:GEHC) reported Q4 adjusted EPS of $1.18, surpassing the $1.07 estimate, with sales of $5.21B also beating the $5.09B estimate. This represents a 9.92% decrease in EPS and a 5.43% increase in sales from the same period last year.
February 06, 2024 | 11:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GE HealthCare Techs reported a strong Q4 with EPS and sales beating estimates, indicating solid financial performance.
GE HealthCare Techs' Q4 earnings and sales surpassing estimates suggest a positive outlook for the company. Despite a year-over-year decrease in EPS, the sales growth and earnings beat are likely to be viewed positively by investors, potentially leading to a short-term uptick in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100